Skip to Content
Global News Select

Correction to Abbott Laboratories Article

Abbott Laboratories' heart device to treat tricuspid regurgitation is called TriClip. "Abbott Laboratories Says FDA Independent Panel Votes to Approve Heart Device," at 7:16 p.m. ET, incorrectly called the device Kind TriClip System.


(END) Dow Jones Newswires

February 13, 2024 19:54 ET (00:54 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Market Updates

Sponsor Center